Breaking News, Financial News

Financial Report: ICON 4Q

Operating income was $92 million for the year, representing 10.2% of revenue.

ICON 4Q

4Q Revenues: $232.1 million (+2%)

4Q Earnings: $22.1 million (-8%)

FY Revenues: $900.0 million (+1%)

FY Earnings: $87.1 million (-5%)

Comments: Operating income was $92 million for the year, representing 10.2% of revenue. This comprised clinical services operating income of $104.8 million or 12.5%, and central lab operating losses of $12.8 million. In the quarter, operating income was $22 million, representing 9.5% of revenue. Clinical services operating income accounted for $26 million or 12.1%, and a central lab operating loss of $4 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters